Nearly half of all trial delays are due to difficulties in patient recruitment - delays that cost millions of dollars in missed market opportunities.
Operational delays in patient recruitment and retention in clinical trials reduce patent exclusivity time and eat into the most commercially productive phase of a new product's lifecycle.
More and more biopharmaceuticals entering the development pipeline have been designed to attack very specific biological targets, necessitating the identification, recruitment and retention of patients that fit an increasingly narrow medical profile. Therefore, pharmaceutical companies and clinical research organizations are seeking innovative ways to optimise their patient recruiting operations and gain a competitive edge.
This event will bring together senior level lifescence experts from the leading pharmaceutical players to benchmark top practices and success stories about:
Brochure request / registration
Stay up to date with patient and physician recruiting initiatives and identify what can be incorporated into the clinical objectives of your team!
